Effector CD8+ cytotoxic T cells have been shown to be specifically associated with favorable prognosis of patients with some malignant tumors, such as glioblastomas, ovarian cancers and pancreatic cancers [22, 24, 25]. This evidence concerns the gene CD8A and pancreatic neoplasm.